This document provides an overview of antiphospholipid syndrome (APS), an autoimmune condition characterized by arterial or venous blood clots and/or pregnancy complications. It defines APS and reviews its epidemiology, pathogenesis, classification (primary/secondary), clinical presentations, diagnostic criteria, treatment approaches including anticoagulation and immunotherapy, and references for further information. Key points include that APS is due to antibodies that activate blood clotting, it commonly occurs with other autoimmune diseases, and treatment involves blood thinners like warfarin to prevent new clots from forming.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots in arteries and veins, pregnancy complications, and the presence of antiphospholipid antibodies. The syndrome can occur alone or in association with other autoimmune diseases like lupus. Treatment involves long-term anticoagulation with blood thinners and aspirin to prevent new clots from forming. Management of pregnancy in APS patients depends on their history and involves low-dose aspirin with or without low or high dose blood thinners.
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by blood clots in arteries or veins and/or pregnancy complications. It results from antibodies that cause blood to clot more easily than normal. Symptoms include blood clots in both arteries and veins as well as pregnancy-related issues. APS can occur on its own or in conjunction with other autoimmune diseases like lupus. Treatment involves blood thinners to prevent clots and aspirin/heparin during pregnancy to prevent complications. Prognosis depends on symptoms, with blood clots requiring long-term anticoagulation and pregnancy morbidity treated to allow successful pregnancies.
This document discusses antiphospholipid antibody syndrome (APS), also known as Hughes syndrome. It is an autoimmune disorder characterized by blood clots and pregnancy complications associated with abnormal antibodies. The syndrome can occur on its own or with lupus. Diagnosis requires certain clinical criteria like blood clots or pregnancy loss along with lab tests showing elevated antibodies on two occasions three months apart. Treatment involves blood thinners like heparin or warfarin to prevent clots. Management of pregnancy in APS patients requires heparin and low-dose aspirin to reduce risks of complications.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots in arteries and veins, pregnancy complications, and the presence of antiphospholipid antibodies. The condition occurs when the immune system produces antibodies that cause blood to clot abnormally. Treatment involves blood thinners and aspirin to prevent clots, with lifelong anticoagulation often needed for recurrent clotting events. Prognosis depends on symptom severity and control, with catastrophic APS having high mortality without aggressive intervention.
Systemic lupus erythematosus (SLE) is an autoimmune disease most common in women of childbearing age. It can affect multiple organ systems. Common manifestations include fatigue, arthritis, rashes, hematologic abnormalities, and kidney involvement. The diagnosis is based on clinical features and autoantibodies. Treatment involves medications to reduce inflammation and suppress the immune system such as antimalarials, corticosteroids, immunosuppressants. Lupus nephritis requires aggressive therapy with corticosteroids and immunosuppressants like cyclophosphamide or mycophenolate mofetil. Research is ongoing into more targeted biologic therapies.
Approach to a patient with positive ana levels (2)Mohit Aggarwal
This document discusses the approach to evaluating a patient with a positive ANA test result. It provides background on ANA testing and discusses the significance of various ANA patterns and titers. The document emphasizes that a positive ANA alone does not indicate a specific disease and must be interpreted based on the clinical context. It then reviews how to approach and evaluate common conditions associated with ANA positivity like SLE, Scleroderma, RA, and Sjogren's Syndrome.
Antiphospholipid syndrome (APS), also known as Hughes syndrome, is an autoimmune disorder characterized by abnormal blood clotting caused by antiphospholipid antibodies. It increases the risk of blood clots forming in veins and arteries, which can lead to complications like heart attacks, strokes, miscarriages, and preeclampsia. APS is diagnosed through blood tests detecting antiphospholipid antibodies and a history of blood clots, pregnancy morbidity, or other related health issues. Treatment involves blood thinners and aspirin to prevent clotting. With proper management, most APS patients can lead normal lives.
This document provides an overview of antiphospholipid syndrome (APS), an autoimmune condition characterized by arterial or venous blood clots and/or pregnancy complications. It defines APS and reviews its epidemiology, pathogenesis, classification (primary/secondary), clinical presentations, diagnostic criteria, treatment approaches including anticoagulation and immunotherapy, and references for further information. Key points include that APS is due to antibodies that activate blood clotting, it commonly occurs with other autoimmune diseases, and treatment involves blood thinners like warfarin to prevent new clots from forming.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots in arteries and veins, pregnancy complications, and the presence of antiphospholipid antibodies. The syndrome can occur alone or in association with other autoimmune diseases like lupus. Treatment involves long-term anticoagulation with blood thinners and aspirin to prevent new clots from forming. Management of pregnancy in APS patients depends on their history and involves low-dose aspirin with or without low or high dose blood thinners.
Antiphospholipid syndrome (APS) is an autoimmune condition characterized by blood clots in arteries or veins and/or pregnancy complications. It results from antibodies that cause blood to clot more easily than normal. Symptoms include blood clots in both arteries and veins as well as pregnancy-related issues. APS can occur on its own or in conjunction with other autoimmune diseases like lupus. Treatment involves blood thinners to prevent clots and aspirin/heparin during pregnancy to prevent complications. Prognosis depends on symptoms, with blood clots requiring long-term anticoagulation and pregnancy morbidity treated to allow successful pregnancies.
This document discusses antiphospholipid antibody syndrome (APS), also known as Hughes syndrome. It is an autoimmune disorder characterized by blood clots and pregnancy complications associated with abnormal antibodies. The syndrome can occur on its own or with lupus. Diagnosis requires certain clinical criteria like blood clots or pregnancy loss along with lab tests showing elevated antibodies on two occasions three months apart. Treatment involves blood thinners like heparin or warfarin to prevent clots. Management of pregnancy in APS patients requires heparin and low-dose aspirin to reduce risks of complications.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by blood clots in arteries and veins, pregnancy complications, and the presence of antiphospholipid antibodies. The condition occurs when the immune system produces antibodies that cause blood to clot abnormally. Treatment involves blood thinners and aspirin to prevent clots, with lifelong anticoagulation often needed for recurrent clotting events. Prognosis depends on symptom severity and control, with catastrophic APS having high mortality without aggressive intervention.
Systemic lupus erythematosus (SLE) is an autoimmune disease most common in women of childbearing age. It can affect multiple organ systems. Common manifestations include fatigue, arthritis, rashes, hematologic abnormalities, and kidney involvement. The diagnosis is based on clinical features and autoantibodies. Treatment involves medications to reduce inflammation and suppress the immune system such as antimalarials, corticosteroids, immunosuppressants. Lupus nephritis requires aggressive therapy with corticosteroids and immunosuppressants like cyclophosphamide or mycophenolate mofetil. Research is ongoing into more targeted biologic therapies.
Approach to a patient with positive ana levels (2)Mohit Aggarwal
This document discusses the approach to evaluating a patient with a positive ANA test result. It provides background on ANA testing and discusses the significance of various ANA patterns and titers. The document emphasizes that a positive ANA alone does not indicate a specific disease and must be interpreted based on the clinical context. It then reviews how to approach and evaluate common conditions associated with ANA positivity like SLE, Scleroderma, RA, and Sjogren's Syndrome.
Antiphospholipid syndrome (APS), also known as Hughes syndrome, is an autoimmune disorder characterized by abnormal blood clotting caused by antiphospholipid antibodies. It increases the risk of blood clots forming in veins and arteries, which can lead to complications like heart attacks, strokes, miscarriages, and preeclampsia. APS is diagnosed through blood tests detecting antiphospholipid antibodies and a history of blood clots, pregnancy morbidity, or other related health issues. Treatment involves blood thinners and aspirin to prevent clotting. With proper management, most APS patients can lead normal lives.
This document discusses autoimmune diseases and provides an overview of key concepts. It covers mechanisms of autoimmunity like central and peripheral tolerance. It also discusses theories of autoimmunity such as susceptibility genes and environmental triggers. The document then describes the spectrum of autoimmune disorders including organ-specific and systemic diseases. It concludes by noting the diagnostic problems associated with autoimmune diseases.
This document provides information about systemic lupus erythematosus (SLE). It defines SLE as a multi-system autoimmune disease affecting various organs mediated by autoantibodies and immune complexes. The causes are unknown but may involve genetic, hormonal, and environmental factors. SLE can affect many organ systems like the kidneys, lungs, heart, and nervous system, causing a variety of clinical manifestations. Diagnosis involves evaluating symptoms, medical history, physical exam, and laboratory tests. Treatment depends on disease severity and organ involvement, and may include medications like NSAIDs, antimalarials, corticosteroids, and cytotoxic drugs. Special considerations are given to SLE in pregnancy and neonates.
Antiphospholipid syndrome is an autoimmune condition characterized by abnormal blood clotting due to antibodies against cell membrane phospholipids. It can cause blood clots in both arteries and veins, as well as pregnancy complications such as miscarriage or preeclampsia. The syndrome was first described in the 1980s and is sometimes called Hughes syndrome, after the rheumatologist who played a central role in characterizing the condition. Risk factors include other autoimmune diseases and certain genetic markers.
Prof hanan anti phospholipid syndrome with highlights on criteria and seronegative antiphospholipid
Head of internal medicine, faculty of medicine, Beni-Suef University
First lupus day October 2018
Antiphospholipid syndrome (APS) is characterized by recurrent venous or arterial thrombosis and/or fetal loss. It is associated with persistently elevated levels of antibodies against phospholipids or plasma proteins. Pathophysiology may involve defects in apoptosis, phospholipid-protein complex formation, and complement activation. Clinically, APS can affect many organ systems and cause thrombosis. It occurs more commonly in young to middle-aged adults but can manifest at any age. Pregnancy morbidity includes multiple miscarriages or preterm births. Diagnosis requires positive laboratory tests on two occasions at least 12 weeks apart. Treatment involves anticoagulation and management of thrombosis.
This case report describes a 10-year-old boy presenting with nausea, vomiting, jaundice and abdominal pain. Laboratory and histopathological studies showed features of both Wilson's disease and autoimmune hepatitis. The patient was found to have elevated liver enzymes and copper levels as well as positive autoantibodies. Liver biopsy showed interface hepatitis and high copper content. Given features of both diseases, the patient was treated with immunosuppressants, penicillamine and showed improvement. The report highlights the rare occurrence of simultaneous Wilson's disease and autoimmune hepatitis. Proper diagnosis requires consideration of both diseases and combined treatment may have superior benefits for these patients.
Cervera ricard antiphospholipid syndrome update on pathogenesis diagnosis and...cmid
This document discusses the pathogenesis, diagnosis, and management of antiphospholipid syndrome (APS). It notes that APS can cause thrombosis in 20-30% of cases, as well as recurrent pregnancy loss in 10-15% of cases. Regarding diagnosis, it discusses both classical and unusual clinical manifestations of APS. It also discusses the diagnostic criteria for definite and probable APS. For management, it notes controversies around optimal anticoagulation levels and the use of heparin versus aspirin for pregnancy in APS patients. It also summarizes recommendations for treating catastrophic APS.
The document discusses the antiphospholipid syndrome, which is characterized by the presence of antiphospholipid antibodies and clinical manifestations including thrombotic phenomena and recurrent miscarriages. It defines the diagnostic criteria for antiphospholipid syndrome and describes the different types of antiphospholipid antibodies. It also discusses the varied clinical manifestations with a focus on cutaneous lesions, and reviews current guidelines for treatment and prophylaxis of thrombotic disorders and maternal morbidity associated with antiphospholipid syndrome.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by inflammation in tissues throughout the body. The name comes from a 13th century physician who observed facial lesions resembling a wolf bite. Diagnosis is based on criteria developed by the American College of Rheumatology including malar rash, discoid lesions, arthritis, serositis, renal disease, and immunologic abnormalities. Treatment involves hydroxychloroquine, corticosteroids, immunosuppressants like azathioprine. Lupus nephritis requires aggressive therapy with glucocorticoids, cyclophosphamide or mycophenolate mofetil. Treatment goals are complete or partial renal response through reduction
Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.
SLE is a multisystem autoimmune disease that predominantly affects women of childbearing age and is the most common form of lupus.
The exact cause is still unknown.
For more informations you can read the following file.
Antiphospholipid antibody syndrome (APAS) is caused by antibodies that target phospholipids or phospholipid-binding proteins, activating coagulation and inhibiting natural anticoagulants. This can cause blood clots, recurrent pregnancy loss, or complications like preeclampsia. Two criteria are needed for diagnosis: clinical evidence of blood clots or pregnancy morbidity, and laboratory tests positive for lupus anticoagulant, anticardiolipin antibodies or anti-β2 glycoprotein I. Treatment involves low-dose aspirin and prophylactic heparin during pregnancy. Women with a history of clots may require therapeutic anticoagulation to prevent complications like further clotting events or late fetal loss.
Antiphospholipid syndrome was first described in the 1980s and is characterized by arterial or venous thrombosis, thrombocytopenia, or recurrent fetal loss associated with antiphospholipid antibodies. It is caused by autoimmune production of antibodies against cell membrane phospholipids such as cardiolipin and β2-glycoprotein I, which disrupt the body's normal regulation of blood coagulation and increase the risk of abnormal blood clotting. The syndrome can occur on its own or in association with other autoimmune diseases such as systemic lupus erythematosus.
In this ppt tried to give info about from serum therapy to plasma therapy in treatment of covid-19 is explained in concised form by collecting from so many sources.This ppt consists of about plasma,plasma composition,serum therapy which is invented by scientist and nobel laureate von behring and vaccines of diphtheria and tetanus ,convalescent plasma(CP) therapy procedure , CP application in curing covid-19 disease,and WHO statement about usage of plasma therapy for covid disease are explained in detailed manner.
This document provides a critical evaluation of laboratory tests used in the diagnosis and assessment of acute pancreatitis. It discusses the advantages and limitations of commonly used tests like serum amylase and lipase. While amylase remains an important initial test due to its availability and sensitivity, it lacks specificity. Lipase has greater sensitivity in alcoholic pancreatitis and late presentations, but can also be nonspecifically elevated. No single test can accurately diagnose, assess severity, or determine the etiology of acute pancreatitis. Multiple tests and factors like time of testing must be considered.
This document provides guidelines for the diagnosis and management of autoimmune hepatitis (AIH) as outlined by the American Association for the Study of Liver Diseases (AASLD) in 2010. It defines AIH as a chronic relapsing hepatitis associated with plasma cell infiltration, hypergammaglobulinemia, and positive autoantibodies. The document discusses the epidemiology, natural history, pathogenesis, clinical presentation, diagnostic criteria, histological features, imaging, and treatment of AIH.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by arterial or venous blood clots and/or pregnancy morbidity. It results from antibodies that target phospholipids or proteins that bind phospholipids. APS can occur alone (primary) or with other autoimmune diseases like lupus (secondary). The antibodies are associated with an increased risk of blood clots, heart attacks, strokes, preeclampsia, and fetal loss. Diagnosis requires both clinical criteria of vascular events or pregnancy complications and laboratory detection of antiphospholipid antibodies. Treatment focuses on blood thinners to prevent new clots.
This document discusses anti-phospholipid syndrome (APS), also known as Hughes syndrome. APS is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies. The key points covered include:
1. APS criteria requiring one clinical (thrombosis, pregnancy loss) and one laboratory (lupus anticoagulant, anticardiolipin, anti-beta 2 glycoprotein I antibodies) feature.
2. Treatment involves anticoagulation with heparin and long-term warfarin, with target INRs of 2.0-3.0 for venous thrombosis and 3.0 for arterial thrombosis.
3
1. The document discusses antiphospholipid syndrome (APS), providing definitions, diagnostic criteria, pathogenesis, clinical manifestations, management recommendations, and considerations for special populations.
2. Key points include that APS is an acquired autoimmune disorder associated with recurrent thrombosis and/or pregnancy morbidity, the importance of identifying a high-risk antibody profile to guide treatment, and recommendations for anticoagulation and immunosuppression to prevent recurrent events.
3. Special sections address catastrophic APS, obstetric APS, nephropathy, and neurological manifestations of APS. Management involves controlling risk factors, anticoagulation, immunomodulation for refractory cases, and individualized strategies for special patient groups
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
This document discusses autoimmune diseases and provides an overview of key concepts. It covers mechanisms of autoimmunity like central and peripheral tolerance. It also discusses theories of autoimmunity such as susceptibility genes and environmental triggers. The document then describes the spectrum of autoimmune disorders including organ-specific and systemic diseases. It concludes by noting the diagnostic problems associated with autoimmune diseases.
This document provides information about systemic lupus erythematosus (SLE). It defines SLE as a multi-system autoimmune disease affecting various organs mediated by autoantibodies and immune complexes. The causes are unknown but may involve genetic, hormonal, and environmental factors. SLE can affect many organ systems like the kidneys, lungs, heart, and nervous system, causing a variety of clinical manifestations. Diagnosis involves evaluating symptoms, medical history, physical exam, and laboratory tests. Treatment depends on disease severity and organ involvement, and may include medications like NSAIDs, antimalarials, corticosteroids, and cytotoxic drugs. Special considerations are given to SLE in pregnancy and neonates.
Antiphospholipid syndrome is an autoimmune condition characterized by abnormal blood clotting due to antibodies against cell membrane phospholipids. It can cause blood clots in both arteries and veins, as well as pregnancy complications such as miscarriage or preeclampsia. The syndrome was first described in the 1980s and is sometimes called Hughes syndrome, after the rheumatologist who played a central role in characterizing the condition. Risk factors include other autoimmune diseases and certain genetic markers.
Prof hanan anti phospholipid syndrome with highlights on criteria and seronegative antiphospholipid
Head of internal medicine, faculty of medicine, Beni-Suef University
First lupus day October 2018
Antiphospholipid syndrome (APS) is characterized by recurrent venous or arterial thrombosis and/or fetal loss. It is associated with persistently elevated levels of antibodies against phospholipids or plasma proteins. Pathophysiology may involve defects in apoptosis, phospholipid-protein complex formation, and complement activation. Clinically, APS can affect many organ systems and cause thrombosis. It occurs more commonly in young to middle-aged adults but can manifest at any age. Pregnancy morbidity includes multiple miscarriages or preterm births. Diagnosis requires positive laboratory tests on two occasions at least 12 weeks apart. Treatment involves anticoagulation and management of thrombosis.
This case report describes a 10-year-old boy presenting with nausea, vomiting, jaundice and abdominal pain. Laboratory and histopathological studies showed features of both Wilson's disease and autoimmune hepatitis. The patient was found to have elevated liver enzymes and copper levels as well as positive autoantibodies. Liver biopsy showed interface hepatitis and high copper content. Given features of both diseases, the patient was treated with immunosuppressants, penicillamine and showed improvement. The report highlights the rare occurrence of simultaneous Wilson's disease and autoimmune hepatitis. Proper diagnosis requires consideration of both diseases and combined treatment may have superior benefits for these patients.
Cervera ricard antiphospholipid syndrome update on pathogenesis diagnosis and...cmid
This document discusses the pathogenesis, diagnosis, and management of antiphospholipid syndrome (APS). It notes that APS can cause thrombosis in 20-30% of cases, as well as recurrent pregnancy loss in 10-15% of cases. Regarding diagnosis, it discusses both classical and unusual clinical manifestations of APS. It also discusses the diagnostic criteria for definite and probable APS. For management, it notes controversies around optimal anticoagulation levels and the use of heparin versus aspirin for pregnancy in APS patients. It also summarizes recommendations for treating catastrophic APS.
The document discusses the antiphospholipid syndrome, which is characterized by the presence of antiphospholipid antibodies and clinical manifestations including thrombotic phenomena and recurrent miscarriages. It defines the diagnostic criteria for antiphospholipid syndrome and describes the different types of antiphospholipid antibodies. It also discusses the varied clinical manifestations with a focus on cutaneous lesions, and reviews current guidelines for treatment and prophylaxis of thrombotic disorders and maternal morbidity associated with antiphospholipid syndrome.
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by inflammation in tissues throughout the body. The name comes from a 13th century physician who observed facial lesions resembling a wolf bite. Diagnosis is based on criteria developed by the American College of Rheumatology including malar rash, discoid lesions, arthritis, serositis, renal disease, and immunologic abnormalities. Treatment involves hydroxychloroquine, corticosteroids, immunosuppressants like azathioprine. Lupus nephritis requires aggressive therapy with glucocorticoids, cyclophosphamide or mycophenolate mofetil. Treatment goals are complete or partial renal response through reduction
Common Diagnostic pitfalls with coagulation disorders lies in addressing challenges in preanalytical processes & implementation of algorithms as per newer guidelines.
SLE is a multisystem autoimmune disease that predominantly affects women of childbearing age and is the most common form of lupus.
The exact cause is still unknown.
For more informations you can read the following file.
Antiphospholipid antibody syndrome (APAS) is caused by antibodies that target phospholipids or phospholipid-binding proteins, activating coagulation and inhibiting natural anticoagulants. This can cause blood clots, recurrent pregnancy loss, or complications like preeclampsia. Two criteria are needed for diagnosis: clinical evidence of blood clots or pregnancy morbidity, and laboratory tests positive for lupus anticoagulant, anticardiolipin antibodies or anti-β2 glycoprotein I. Treatment involves low-dose aspirin and prophylactic heparin during pregnancy. Women with a history of clots may require therapeutic anticoagulation to prevent complications like further clotting events or late fetal loss.
Antiphospholipid syndrome was first described in the 1980s and is characterized by arterial or venous thrombosis, thrombocytopenia, or recurrent fetal loss associated with antiphospholipid antibodies. It is caused by autoimmune production of antibodies against cell membrane phospholipids such as cardiolipin and β2-glycoprotein I, which disrupt the body's normal regulation of blood coagulation and increase the risk of abnormal blood clotting. The syndrome can occur on its own or in association with other autoimmune diseases such as systemic lupus erythematosus.
In this ppt tried to give info about from serum therapy to plasma therapy in treatment of covid-19 is explained in concised form by collecting from so many sources.This ppt consists of about plasma,plasma composition,serum therapy which is invented by scientist and nobel laureate von behring and vaccines of diphtheria and tetanus ,convalescent plasma(CP) therapy procedure , CP application in curing covid-19 disease,and WHO statement about usage of plasma therapy for covid disease are explained in detailed manner.
This document provides a critical evaluation of laboratory tests used in the diagnosis and assessment of acute pancreatitis. It discusses the advantages and limitations of commonly used tests like serum amylase and lipase. While amylase remains an important initial test due to its availability and sensitivity, it lacks specificity. Lipase has greater sensitivity in alcoholic pancreatitis and late presentations, but can also be nonspecifically elevated. No single test can accurately diagnose, assess severity, or determine the etiology of acute pancreatitis. Multiple tests and factors like time of testing must be considered.
This document provides guidelines for the diagnosis and management of autoimmune hepatitis (AIH) as outlined by the American Association for the Study of Liver Diseases (AASLD) in 2010. It defines AIH as a chronic relapsing hepatitis associated with plasma cell infiltration, hypergammaglobulinemia, and positive autoantibodies. The document discusses the epidemiology, natural history, pathogenesis, clinical presentation, diagnostic criteria, histological features, imaging, and treatment of AIH.
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by arterial or venous blood clots and/or pregnancy morbidity. It results from antibodies that target phospholipids or proteins that bind phospholipids. APS can occur alone (primary) or with other autoimmune diseases like lupus (secondary). The antibodies are associated with an increased risk of blood clots, heart attacks, strokes, preeclampsia, and fetal loss. Diagnosis requires both clinical criteria of vascular events or pregnancy complications and laboratory detection of antiphospholipid antibodies. Treatment focuses on blood thinners to prevent new clots.
This document discusses anti-phospholipid syndrome (APS), also known as Hughes syndrome. APS is an autoimmune disorder characterized by vascular thrombosis and/or pregnancy morbidity in the presence of antiphospholipid antibodies. The key points covered include:
1. APS criteria requiring one clinical (thrombosis, pregnancy loss) and one laboratory (lupus anticoagulant, anticardiolipin, anti-beta 2 glycoprotein I antibodies) feature.
2. Treatment involves anticoagulation with heparin and long-term warfarin, with target INRs of 2.0-3.0 for venous thrombosis and 3.0 for arterial thrombosis.
3
1. The document discusses antiphospholipid syndrome (APS), providing definitions, diagnostic criteria, pathogenesis, clinical manifestations, management recommendations, and considerations for special populations.
2. Key points include that APS is an acquired autoimmune disorder associated with recurrent thrombosis and/or pregnancy morbidity, the importance of identifying a high-risk antibody profile to guide treatment, and recommendations for anticoagulation and immunosuppression to prevent recurrent events.
3. Special sections address catastrophic APS, obstetric APS, nephropathy, and neurological manifestations of APS. Management involves controlling risk factors, anticoagulation, immunomodulation for refractory cases, and individualized strategies for special patient groups
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)MuskanShingari
Statistics- Statistics is the science of collecting, organizing, presenting, analyzing and interpreting numerical data to assist in making more effective decisions.
A statistics is a measure which is used to estimate the population parameter
Parameters-It is used to describe the properties of an entire population.
Examples-Measures of central tendency Dispersion, Variance, Standard Deviation (SD), Absolute Error, Mean Absolute Error (MAE), Eigen Value
Dr. Tan's Balance Method.pdf (From Academy of Oriental Medicine at Austin)GeorgeKieling1
Home
Organization
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
Academy of Oriental Medicine at Austin
About AOMA: The Academy of Oriental Medicine at Austin offers a masters-level graduate program in acupuncture and Oriental medicine, preparing its students for careers as skilled, professional practitioners. AOMA is known for its internationally recognized faculty, award-winning student clinical internship program, and herbal medicine program. Since its founding in 1993, AOMA has grown rapidly in size and reputation, drawing students from around the nation and faculty from around the world. AOMA also conducts more than 20,000 patient visits annually in its student and professional clinics. AOMA collaborates with Western healthcare institutions including the Seton Family of Hospitals, and gives back to the community through partnerships with nonprofit organizations and by providing free and reduced price treatments to people who cannot afford them. The Academy of Oriental Medicine at Austin is located at 2700 West Anderson Lane. AOMA also serves patients and retail customers at its south Austin location, 4701 West Gate Blvd. For more information see www.aoma.edu or call 512-492-303434.
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
STUDIES IN SUPPORT OF SPECIAL POPULATIONS: GERIATRICS E7shruti jagirdar
Unit 4: MRA 103T Regulatory affairs
This guideline is directed principally toward new Molecular Entities that are
likely to have significant use in the elderly, either because the disease intended
to be treated is characteristically a disease of aging ( e.g., Alzheimer's disease) or
because the population to be treated is known to include substantial numbers of
geriatric patients (e.g., hypertension).
Gene therapy can be broadly defined as the transfer of genetic material to cure a disease or at least to improve the clinical status of a patient.
One of the basic concepts of gene therapy is to transform viruses into genetic shuttles, which will deliver the gene of interest into the target cells.
Safe methods have been devised to do this, using several viral and non-viral vectors.
In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The biggest hurdle faced by medical research in gene therapy is the availability of effective gene-carrying vectors that meet all of the following criteria:
Protection of transgene or genetic cargo from degradative action of systemic and endonucleases,
Delivery of genetic material to the target site, i.e., either cell cytoplasm or nucleus,
Low potential of triggering unwanted immune responses or genotoxicity,
Economical and feasible availability for patients .
Viruses are naturally evolved vehicles that efficiently transfer their genes into host cells.
Choice of viral vector is dependent on gene transfer efficiency, capacity to carry foreign genes, toxicity, stability, immune responses towards viral antigens and potential viral recombination.
There are a wide variety of vectors used to deliver DNA or oligo nucleotides into mammalian cells, either in vitro or in vivo.
The most common vector system based on retroviruses, adenoviruses, herpes simplex viruses, adeno associated viruses.
13. Antiphospholipid syndrome (APS)
The prevalence of aPL is estimated to be 1-
5% of the general population.
Only a minority of these individuals develop
APS.
Berkman, Song, 2021
17. Diagnosis of APS
Clinical criteria (at least one) Laboratory criteria (at least one)
Miyakis et al, 2006
18. Clinical criteria of APS
1- Confirmed thrombosis
Arterial thrombosis: more frequent in
males
Deep veins thrombosis: more frequent in
females
Giannakopoulos B and Krilis, 2013
19. Clinical criteria of APS
2- Pregnancy morbidity
1≤ unexplained deaths of a morphologically
normal fetus (after 10th WOG)
1≤ premature delivery of a morphologically
normal neonate (before 34th WOG)
3 ≤ unexplained consecutive spontaneous
abortions (before 10th WOG)
Giannakopoulos B and Krilis, 2013
29. Antiphospholipid syndrome (APS)
Summary
APS is an autoimmune disease
Patients have: thrombosis, pregnancy
morbidity, persistent aPL
Diagnosis: depends on clinical criteria and lab
criteria
30. Antiphospholipid syndrome (APS)
References
Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan
D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy
morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical
review of the literature. Arthritis Care Res (Hoboken). 2013;65(11):1869-1873.
Berkman SA, Song SS. Ischemic Stroke in the Young. Clin Appl Thromb Hemost.
2021;27:10760296211002274.
Knight JS, Kanthi Y. Mechanisms of immunothrombosis and vasculopathy in
antiphospholipid syndrome. Semin Immunopathol. 2022;1-16.
Linnemann B. Antiphospholipid syndrome - an update. Vasa. 2018;47(6):451-464.
31. Antiphospholipid syndrome (APS)
References
Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an
update of the classification criteria for definite antiphospholipid syndrome (APS). J
Thromb Haemost. 2006;4(2):295-306.
Petri M. Antiphospholipid syndrome. Transl Res. 2020;225:70-81.
Rodríguez CM, Velásquez-Berrío M, Rúa C, et al. Antiphospholipid Antibodies
From Women With Pregnancy Morbidity and Vascular Thrombosis Induce
Endothelial Mitochondrial Dysfunction, mTOR Activation, and Autophagy. Front
Physiol. 2021;12:706743. Published 2021 Nov 29.